Name: UMIN ID:
Unique ID issued by UMIN | UMIN000004779 |
---|---|
Receipt number | R000005691 |
Scientific Title | Treatment with propagermanium, a CCR2 inhibitor, for diabetic nephropathy |
Date of disclosure of the study information | 2011/01/04 |
Last modified on | 2017/06/27 09:42:36 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/12/22 18:16:48 | ||
2 | Update | 2011/06/22 14:30:47 | Recruitment status |
|
3 | Update | 2011/12/24 11:49:15 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
4 | Update | 2014/06/24 10:07:07 | Email Address Address TEL |
|
5 | Update | 2014/06/24 10:13:22 | Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria Target sample size |
|
6 | Update | 2014/08/20 17:49:07 | Stratification Institution consideration Blocking |
|
7 | Update | 2014/12/22 16:17:58 | Institutions |
|
8 | Update | 2016/04/13 22:13:00 | Name of primary person or sponsor Organization Organization Organization Category of Funding Organization |
|
9 | Update | 2016/05/13 18:25:27 | Recruitment status |
|
10 | Update | 2016/12/27 19:38:12 | Division name Division name Division name Division name |
|
11 | Update | 2017/06/27 09:42:36 | Recruitment status Last follow-up date |